[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Schneerson et al., 1982 - Google Patents

Bacterial capsular polysaccharide conjugates.

Schneerson et al., 1982

Document ID
12674833154184571820
Author
Schneerson R
Robbins J
Egan W
Zon G
Sutton A
Vann W
Kaijser B
Publication year
Publication venue
SEMIN. INFECT. DIS. 1982.

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • A61K47/4833Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

Similar Documents

Publication Publication Date Title
US4619828A (en) Polysaccharide exotoxoid conjugate vaccines
FI79024C (en) Process for the preparation of Haemophilus influenzae b-polysaccharide xotoxoid conjugate vaccine.
US4711779A (en) Glycoproteinic conjugates having trivalent immunogenic activity
US5955079A (en) Dual carrier immunogenic construct
EP0720485B1 (en) Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
CA2142981C (en) Vaccines against group c neisseria meningitidis
US5445817A (en) Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
AU740784B2 (en) Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
US4644059A (en) Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
MC2178A1 (en) PNEUMOLYSIN MUTANTS AND PNEUMOCOCCUS-BASED VACCINES MADE FROM THESE MUTANTS
Bergquist et al. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates
US4771127A (en) Nontoxic pseudomonas aeruginosa polysaccharide-tetanus toxoid and polysaccharide-toxin a conjugate vaccines
AU627455B2 (en) Haemophilus influenza type B oxidized polysaccharide-outer membrane protein conjugate vaccine
Schneerson et al. Bacterial capsular polysaccharide conjugates.
Peeters et al. Preparation of polysaccharide-conjugate vaccines
Paoletti et al. Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen
JP2000507252A (en) Method and vaccine for producing immunological substance
Pier et al. Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa
Michon et al. Combination conjugate vaccines against multiple serotypes of group B streptococci
Schneerson et al. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6 SA polysaccharide-protein conjugates.
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.
JP2012116850A (en) Production of immunogenic construct using soluble carbohydrate activated via organic cyanylating reagent
NO157603B (en) PROCEDURE FOR THE PREPARATION OF A WATER-SUBSTANTIAL COVAL NT POLYSACCHARID DIPTERY / TOXOID CONJUGATE AND A HAPTEN, ESSENTIAL FREE OF PROTEIN AND NUCLEIC ACID.